Skip to content
November 17, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Redefining the Standard of Care: Insights from the EMBARK Trial on High-Risk Biochemical Recurrence redefining-the-standard-of-care-insights-from-the-embark-trial-on-high-risk-biochemical-recurrence
  • Clinical Oncology Education

Redefining the Standard of Care: Insights from the EMBARK Trial on High-Risk Biochemical Recurrence

Asro August 21, 2026
In the rapidly evolving landscape of oncology, the management of prostate cancer—specifically cases marked by high-risk biochemical...
Read More Read more about Redefining the Standard of Care: Insights from the EMBARK Trial on High-Risk Biochemical Recurrence
The Biotech Gold Rush: Mapping the 50 Best-Funded Private Innovators of 2026 the-biotech-gold-rush-mapping-the-50-best-funded-private-innovators-of-2026
  • Chemotherapy and Targeted Therapy

The Biotech Gold Rush: Mapping the 50 Best-Funded Private Innovators of 2026

Lina Hope August 21, 2026
The biotechnology landscape in 2026 is defined by a paradox of caution and abundance. While the broader...
Read More Read more about The Biotech Gold Rush: Mapping the 50 Best-Funded Private Innovators of 2026
The Crisis of Confidence: Public Misinformation, Environmental Claims, and the Rise of AI-Generated Health Fraud the-crisis-of-confidence-public-misinformation-environmental-claims-and-the-rise-of-ai-generated-health-fraud
  • Breast Cancer Legislation and Policy

The Crisis of Confidence: Public Misinformation, Environmental Claims, and the Rise of AI-Generated Health Fraud

Nana Muazin August 21, 2026
Volume 52 | August 13, 2026 In an era defined by rapid technological advancement and a shifting...
Read More Read more about The Crisis of Confidence: Public Misinformation, Environmental Claims, and the Rise of AI-Generated Health Fraud
Data as a Lifeline: METAvivor Advocates for Robust 2027 Funding for National Cancer Registries data-as-a-lifeline-metavivor-advocates-for-robust-2027-funding-for-national-cancer-registries
  • Metastatic Breast Cancer Research

Data as a Lifeline: METAvivor Advocates for Robust 2027 Funding for National Cancer Registries

Laily UPN August 21, 2026
In the complex architecture of oncology research and public health, the most potent weapon is often not...
Read More Read more about Data as a Lifeline: METAvivor Advocates for Robust 2027 Funding for National Cancer Registries
Revolutionary IgE Antibody Unlocks New Hope Against Ovarian Cancer, Reactivating Dormant Immune Defenses revolutionary-ige-antibody-unlocks-new-hope-against-ovarian-cancer-reactivating-dormant-immune-defenses
  • Medical Research and Clinical Trials

Revolutionary IgE Antibody Unlocks New Hope Against Ovarian Cancer, Reactivating Dormant Immune Defenses

Rifan Muazin August 21, 2026
London, UK – [Date of Publication] – A groundbreaking study from King’s College London has unveiled the...
Read More Read more about Revolutionary IgE Antibody Unlocks New Hope Against Ovarian Cancer, Reactivating Dormant Immune Defenses
FDA Approves Gedatolisib (Revtorpyk): A New Frontier in the Treatment of HR-Positive/HER2-Negative Metastatic Breast Cancer fda-approves-gedatolisib-revtorpyk-a-new-frontier-in-the-treatment-of-hr-positive-her2-negative-metastatic-breast-cancer
  • Patient Advocacy and Support

FDA Approves Gedatolisib (Revtorpyk): A New Frontier in the Treatment of HR-Positive/HER2-Negative Metastatic Breast Cancer

Ali Ikhwan August 21, 2026
The landscape of metastatic breast cancer (MBC) treatment has undergone a significant transformation with the recent U.S....
Read More Read more about FDA Approves Gedatolisib (Revtorpyk): A New Frontier in the Treatment of HR-Positive/HER2-Negative Metastatic Breast Cancer
A New Era for Genomic Science: ASHG Announces Strategic Publishing Partnership with Oxford University Press a-new-era-for-genomic-science-ashg-announces-strategic-publishing-partnership-with-oxford-university-press-2
  • Genomics and Precision Medicine

A New Era for Genomic Science: ASHG Announces Strategic Publishing Partnership with Oxford University Press

Raul Delapena Setiawan August 21, 2026
ROCKVILLE, MD — In a move set to reshape the landscape of scientific communication within the life...
Read More Read more about A New Era for Genomic Science: ASHG Announces Strategic Publishing Partnership with Oxford University Press
The Strategic Imperative: How Corporate-Nonprofit Partnerships Drive Mutual Value and Lasting Social Impact the-strategic-imperative-how-corporate-nonprofit-partnerships-drive-mutual-value-and-lasting-social-impact
  • Survivorship and Post-Treatment

The Strategic Imperative: How Corporate-Nonprofit Partnerships Drive Mutual Value and Lasting Social Impact

Evan Lee Salim August 21, 2026
In the modern corporate landscape, Corporate Social Responsibility (CSR) has graduated from a peripheral "nice-to-have" initiative into...
Read More Read more about The Strategic Imperative: How Corporate-Nonprofit Partnerships Drive Mutual Value and Lasting Social Impact
Navigating the Shifting Tides: The Evolving Landscape of Childhood Infectious Diseases in the US navigating-the-shifting-tides-the-evolving-landscape-of-childhood-infectious-diseases-in-the-us
  • Medical Research and Clinical Trials

Navigating the Shifting Tides: The Evolving Landscape of Childhood Infectious Diseases in the US

Nila Kartika Wati August 21, 2026
The United States has long been at the forefront of combating infectious diseases, particularly those that disproportionately...
Read More Read more about Navigating the Shifting Tides: The Evolving Landscape of Childhood Infectious Diseases in the US
A New Frontier in Oncology: Experimental Immunotherapy Offers Hope for Bladder-Sparing Cancer Treatment a-new-frontier-in-oncology-experimental-immunotherapy-offers-hope-for-bladder-sparing-cancer-treatment
  • Clinical Oncology Education

A New Frontier in Oncology: Experimental Immunotherapy Offers Hope for Bladder-Sparing Cancer Treatment

Nana August 21, 2026
For decades, the standard of care for patients suffering from high-risk, non-muscle-invasive bladder cancer (NMIBC) who failed...
Read More Read more about A New Frontier in Oncology: Experimental Immunotherapy Offers Hope for Bladder-Sparing Cancer Treatment

Posts pagination

Previous 1 … 430 431 432 433 434 435 436 … 906 Next

Recent Posts

  • Ibuprofen: Beyond Pain Relief – Unearthing a Potential Anti-Cancer Ally
  • CG Oncology’s Gene Therapy Shows Remarkable Efficacy in Pivotal NMIBC Trial, Paving Way for Broader Regulatory Submission
  • Nourishing the Fight: How Real Food Can Empower Breast Cancer Patients and Survivors to Combat Inflammation
  • The Algorithmic Frontier: How Artificial Intelligence is Redefining Breast Cancer Risk and Health Equity
  • FDA Mandates Vision Warning for GLP-1 Receptor Agonists Amid Scientific Debate and Litigation

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

ibuprofen-beyond-pain-relief-unearthing-a-potential-anti-cancer-ally
  • Medical Research and Clinical Trials

Ibuprofen: Beyond Pain Relief – Unearthing a Potential Anti-Cancer Ally

Iffa Jayyana November 16, 2026
cg-oncologys-gene-therapy-shows-remarkable-efficacy-in-pivotal-nmibc-trial-paving-way-for-broader-regulatory-submission
  • Medical Research and Clinical Trials

CG Oncology’s Gene Therapy Shows Remarkable Efficacy in Pivotal NMIBC Trial, Paving Way for Broader Regulatory Submission

Reynand Wu November 16, 2026
nourishing-the-fight-how-real-food-can-empower-breast-cancer-patients-and-survivors-to-combat-inflammation
  • Patient Advocacy and Support

Nourishing the Fight: How Real Food Can Empower Breast Cancer Patients and Survivors to Combat Inflammation

Evan Lee Salim November 16, 2026
A female doctor sits at her desk and talks to a female patient while looking at her mamogram. Brest cancer
  • Patient Advocacy and Support

The Algorithmic Frontier: How Artificial Intelligence is Redefining Breast Cancer Risk and Health Equity

Raul Delapena Setiawan November 16, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.